06/26/2025
3:30 PM | Artiva Biotherapeutics (Issuer)
DANIELS BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:30 PM | Artiva Biotherapeutics (Issuer)
Miralles Gines Diego (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:30 PM | Artiva Biotherapeutics (Issuer)
Stoppel Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:30 PM | Artiva Biotherapeutics (Issuer)
HOUGEN ELIZABETH L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:30 PM | Artiva Biotherapeutics (Issuer)
Baker Daniel G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:30 PM | Artiva Biotherapeutics (Issuer)
MOORE ALISON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2025
3:02 PM | Artiva Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
7:03 AM | Artiva Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
7:06 AM | Artiva Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2025
8:34 PM | Artiva Biotherapeutics (Filer)
| Form DEF 14A | |
04/28/2025
8:36 PM | Artiva Biotherapeutics (Filer)
| Form DEFA14A | |
Get the Latest News and Ratings for ARTV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Artiva Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/28/2025
8:43 PM | Artiva Biotherapeutics (Filer)
| Form ARS | |
04/23/2025
7:14 PM | Artiva Biotherapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G | |
03/24/2025
3:09 PM | Artiva Biotherapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2025
3:35 PM | Artiva Biotherapeutics (Issuer)
Aslan Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:15 PM | Artiva Biotherapeutics (Issuer)
Bush Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:15 PM | Artiva Biotherapeutics (Issuer)
Krishnamohan Neha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:15 PM | Artiva Biotherapeutics (Issuer)
Horan Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:15 PM | Artiva Biotherapeutics (Issuer)
Graef Thorsten (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:15 PM | Artiva Biotherapeutics (Issuer)
Raymon Heather (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
3:32 PM | Artiva Biotherapeutics (Issuer)
Baker Daniel G. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/29/2025
3:33 PM | Artiva Biotherapeutics (Issuer)
Baker Daniel G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
3:07 PM | Artiva Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:56 PM | Artiva Biotherapeutics (Subject)
venBio Global Strategic Fund III, L.P. (Filed by)
| Form SC 13G/A | |
10/22/2024
7:14 PM | Artiva Biotherapeutics (Issuer)
MOORE ALISON (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
7:18 PM | Artiva Biotherapeutics (Issuer)
MOORE ALISON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
3:13 PM | Artiva Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
3:16 PM | Artiva Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
6:00 PM | Artiva Biotherapeutics (Subject)
venBio Global Strategic Fund III, L.P. (Filed by)
| Form SC 13G | |
08/01/2024
3:17 PM | 5AM Ventures VI, L.P. (Filed by)
Artiva Biotherapeutics (Subject)
| Form SC 13G | |
08/01/2024
3:18 PM | Artiva Biotherapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G | |
07/29/2024
3:29 PM | Artiva Biotherapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D | |
07/29/2024
3:15 PM | Artiva Biotherapeutics (Subject)
GC Corp. (Filed by)
| Form SC 13D | |
07/24/2024
3:27 PM | Artiva Biotherapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:15 PM | 5AM Opportunities II , LLC (0001873515) (Reporting)
5AM Opportunities II, L.P. (Reporting)
5AM Partners VI, LLC (Reporting)
5AM Ventures VI, L.P. (Reporting)
Artiva Biotherapeutics (Issuer)
PARMAR KUSH (Reporting)
Schwab Andrew J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
7:18 PM | Artiva Biotherapeutics (Issuer)
Aslan Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
7:22 PM | Artiva Biotherapeutics (Issuer)
Huh Yong-Jun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
7:25 PM | Artiva Biotherapeutics (Issuer)
GC Cell Corp (Reporting)
GC Corp. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
7:26 PM | Adelman Robert J (Reporting)
Artiva Biotherapeutics (Issuer)
GOODMAN COREY S (Reporting)
venBio Global Strategic Fund III, L.P. (Reporting)
VENBIO GLOBAL STRATEGIC GP III, L.P. (Reporting)
VENBIO GLOBAL STRATEGIC GP III, LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
7:28 PM | Artiva Biotherapeutics (Issuer)
Wellington Biomedical Innovation Master Investors I L.P. (0001787092) (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
4:30 PM | Artiva Biotherapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Special gold investment soars 2,300% ... 5,090% ... 9,850% (Ad) In my 54 years as an investor, I’ve seen my share of gold bull markets.
But nothing comes close to the rally right now.
Over the past few weeks alone, the yellow metal surged as high as $3,500 — the highest level on record.
So far this bull run playing out exactly as me and my analysts have predicted. Here’s exactly how we see this gold bull market play out. |
07/22/2024
3:19 PM | Artiva Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2024
11:15 PM | Artiva Biotherapeutics (Filer)
| Form EFFECT | |
07/18/2024
7:14 PM | Adelman Robert J (Reporting)
Artiva Biotherapeutics (Issuer)
GOODMAN COREY S (Reporting)
venBio Global Strategic Fund III, L.P. (Reporting)
VENBIO GLOBAL STRATEGIC GP III, L.P. (Reporting)
VENBIO GLOBAL STRATEGIC GP III, LTD (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:00 PM | Artiva Biotherapeutics (Issuer)
Aslan Fred (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:00 PM | Artiva Biotherapeutics (Issuer)
Bush Jennifer (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:01 PM | Artiva Biotherapeutics (Issuer)
Horan Christopher (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:01 PM | Artiva Biotherapeutics (Issuer)
Krishnamohan Neha (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:01 PM | Artiva Biotherapeutics (Issuer)
Graef Thorsten (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:02 PM | Artiva Biotherapeutics (Issuer)
Bessen Laura (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:02 PM | Artiva Biotherapeutics (Issuer)
Huh Yong-Jun (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:02 PM | Artiva Biotherapeutics (Issuer)
Raymon Heather (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:03 PM | Artiva Biotherapeutics (Issuer)
DANIELS BRIAN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:04 PM | Artiva Biotherapeutics (Issuer)
HOUGEN ELIZABETH L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:05 PM | Artiva Biotherapeutics (Issuer)
GC Cell Corp (Reporting)
GC Corp. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:05 PM | Artiva Biotherapeutics (Issuer)
Stoppel Laura (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:06 PM | Artiva Biotherapeutics (Issuer)
Wellington Biomedical Innovation Master Investors I L.P. (0001787092) (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:06 PM | Artiva Biotherapeutics (Issuer)
Miralles Gines Diego (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:06 PM | 5AM Partners VI, LLC (Reporting)
5AM Ventures VI, L.P. (Reporting)
Artiva Biotherapeutics (Issuer)
PARMAR KUSH (Reporting)
Schwab Andrew J. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:08 PM | Artiva Biotherapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
4:55 PM | Artiva Biotherapeutics (Filer)
| Form S-1MEF | |
07/15/2024
5:07 AM | Artiva Biotherapeutics (Filer)
| Form S-1/A | |
